CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis
Open Access
- 23 January 2012
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 18
Abstract
Background: Granulocytes generally exert protective roles in the central nervous system (CNS), but recent studies suggest that they can be detrimental in experimental autoimmune encephalomyelitis (EAE), the most common model of multiple sclerosis. While the cytokines and adhesion molecules involved in granulocyte adhesion to the brain vasculature have started to be elucidated, the required chemokines remain undetermined.Methods: CXCR2 ligand expression was examined in the CNS of mice suffering from EAE or exposed to bacterial toxins by quantitative RT-PCR andin situhybridization. CXCL1 expression was analyzed in IL-6-treated endothelial cell cultures by quantitative RT-PCR and ELISA. Granulocytes were counted in the brain vasculature after treatment with a neutralizing anti-CXCL1 antibody using stereological techniques.Results: CXCL1 was the most highly expressed ligand of the granulocyte receptor CXCR2 in the CNS of mice subjected to EAE or infused with lipopolysaccharide (LPS) or pertussis toxin (PTX), the latter being commonly used to induce EAE. IL-6 upregulated CXCL1 expression in brain endothelial cells by acting transcriptionally and mediated the stimulatory effect of PTX on CXCL1 expression. The anti-CXCL1 antibody reduced granulocyte adhesion to brain capillaries in the three conditions under study. Importantly, it attenuated EAE severity when given daily for a week during the effector phase of the disease.Conclusions: This study identifies CXCL1 not only as a key regulator of granulocyte recruitment into the CNS, but also as a new potential target for the treatment of neuroinflammatory diseases such as multiple sclerosis.Keywords
This publication has 48 references indexed in Scilit:
- Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic CellsJournal of Neuroscience, 2010
- CXCR2 Signaling Protects Oligodendrocytes and Restricts Demyelination in a Mouse Model of Viral-Induced DemyelinationPLOS ONE, 2010
- Pertussis Toxin and Adenylate Cyclase Toxin: Key Virulence Factors of Bordetella Pertussis and Cell Biology ToolsFuture Microbiology, 2010
- Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune EncephalomyelitisImmunity, 2010
- Initiation and Progression of Axonopathy in Experimental Autoimmune EncephalomyelitisJournal of Neuroscience, 2009
- Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosisExperimental Neurology, 2009
- Autoimmune T cell responses in the central nervous systemNature Reviews Immunology, 2009
- Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating diseaseBlood, 2009
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionJournal of Experimental Medicine, 2008
- The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseJournal of Experimental Medicine, 2008